Goniothalamus species are used in widespread medicines for abortion, anti-aging, body pains, rheumatism, skin complaints, typhoid fever, tympanites, stomach ache and fever. The present study reviews the distribution of species along with their synonyms, their traditional usage, and correlated chemical compounds of Goniothalamus species with stress on the authentication of their ethnobotanical uses. The findings in some Goniothalamus species suggest that the chemical nature of their derivatives, such as acetogenins and styryl-lactones, may justify the use of these species against cancer in Asian traditional medicines due to their cytotoxic potential.
Roots
Decoction of the roots are given as a postpartum remedy and for abortion. Root decoction is given for anti-aging purposes. Mixed with Eurycoma longifolia, it is used as a male tonic. Different parts of Goniothalamus macrophyllus are used by the Temuan in Peninsular Malaysia to treat various ailments such as body pains, rheumatism, and skin complaints. The decoction of the root is used to eliminate excessive gas in body. The decoction is used as a lotion to treat body pains and rheumatism Pounded leaves and bark are used for skin complaints.
[ G. scortechinii --A decoction of G. scortechinii is given as a postpartum protective remedy. [8, 106] G. tapis Miq.
Kenarak, gertimang(Malaya), Naara, Chi-no-koh (Thailand)
The roots of G. tapis Miq. are used as an abortifacient during early months of pregnancy. In Java, Indonesia, an infusion of the roots are used to treat typhoid fever. G. laoticus
Goniothalamus laoticus is being used traditionally as a tonic and a febrifuge by the local people in the northeastern part of Thailand. [20, 111] Goniothalamus uvaroides King
They are used traditionally as postpartum protective remedies, abortifacients, and to treat typhoid fever, rheumatism, and headache. [19, 114] Goniothalamus cheliensis. The bark of Goniothalamus giganteus consist of Gigantrionenin (2),4-Deoxyannomontacin (3), Gonionenine (4), (2,4-cis and trans)-annomontacinone (5), annonacin (6), 4-Acetylgigantetrocin (7), Goniotrionin, Gigantransenin A (9), Gigantransenin B, Gigantrasenin C (10), Goniotetrocin, (2,4-cis and trans) Gonioneninone, Goniothalamicin (11), Pyranicin (12), Pyragonicin, (2,4-cis and trans)-gigantecinone, 4-deoxygigantecin, Giganin (64), Giganenin, 4-deoxygigantecin, ()-goniofupyrone, gigantetrocin, gigantriocin, gonioheptolides A, gonioheptolides B, Goniodenin, Goniocin, Gigantransenins A, B, C, Goniotriol, 2,4-cis and -trans)-xylomaticinones, Goniotricin, Goniothalenol, Goniotetracin, (2,4-cis and trans)-gonioneninone, goniobutenolides A and B, pyragonicin. Its stem bark consists of 9-deoxygoniopypyrone and 7-epi-Goniofufurone. Aerial part of Goniothalamus gardneri contains 2′-hydroxy-4,4′,6′-trimethoxychalcone (flavokawain A) (13), 2′,4′-dihydroxy-4,6′-dimethoxydihydrochalcone (14), 4,2′,4′-trihydroxy-6′-methoxydihydrochalcone, 5,7,4′-trimethoxyflavanone (15) (naringenin trimethyl ether), 7-hydroxy-5,4′-dimethoxyflavanone (tsugafolin) (16), (rel)-1β,2α-di-(2,4-dihydroxy-6-methoxybenzoyl)-3β,4α-di-(4-methoxyphenyl)-cyclobutane, 2′,4′-dihydroxy-4,6′-dimethoxychalcone, 2′-hydroxy-4,4′,6′-trimethoxydihydrochalcone, whereas its roots consist of Gardnerilin A (17), Gardnerilin B (18). All remaining species along with their references are mentioned in Table 4 .
HATASO rabm.scholasticahq.com Goniothalamus giganteus Stem bark 9-Deoxygoniopypyrone and 7-epi-Goniofufurone [47, 94] Goniothalamus gardneri Aerial part
Goniothalamus gardneri
Root Gardnerilin A (17), Gardnerilin B (18) [49, 90] Goniothalamus thwaitesii Aerial part Goniothalamus macrophyllus Stem 
Goniothalamus australis

Goniothalamus albiflous Ban
Leaf oil α-Pinene, caryophyllene oxide, and 1,8-cineole [94, 44] (Continued ) Goniothalamus cheliensis Roots Goniolactones AF, gonioquinone, and goniofufurone acetonide [106, 107, 68, 100] Goniothalamus cheliensis Root bark Goniolactones GI [108, 89] Goniothalamus wightii Leaves and stem Pypyrones [109, 74] Goniothalamus donnaiensis Roots Donhepocin, 34-epi-donhepocin, donhexocin, donbutocin, goniodonin, 34-epi-goniodonin, cis-goniodonin, 34-epi-cis-goniodonin, donnaienin C, 34-EPI-donnaienin C, donnaienin D, 34-EPI-donnaienin D, donnaienin [110] [111] [112] [113] [ 59, 76, 78, 85] Goniothalamus marcanii Stem bark Azaanthraquinones and 3-Aminonaphthoquinone [114, 77] Goniothalamus marcanii Leaves and twigs 5-hydroxygoniothalamin, 5-acetylgoniothalamin, and goniopypyrone (42). [115, 80] Goniothalamus arvensis Stem bark ()-Garvensintriol, ()-etharvendiol, ()-goniofufurone (55) [116, 82] Goniothalamus tomentosus Stem bark and roots Aristololactam BII, ouregidione , stigmasterol [117, 83] Goniothalamus woodii Root Goniothalamin (26), 5-acetoxygoniothalamin and goniotriol [118, 86] Goniothalamus borneensis Bark Goniothalesdiol and goniothalactam [119, 88] Goniothalamus dolichocarpus Stem bark ()-5β-Hydroxygoniothalamin [120, 92] Goniothalamus ridleyi Root 5-Hydroxy-6-[(E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one [121, 103] Goniothalamus dolichocarpus Stem bark 5-Hydroxy-6-[(E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one [121, 103] Goniothalamus sesquipedalis Leaves and twigs Goniopedaline, aristololactam A-II, taliscanine, aurantiamide acetate, β-sitosterol, β-d-glucoside [122, 121] Goniothalamus sesquipedalis Stem bark 6S-(5-S-acetoxy)-7S, 8R-epoxystyryl-5,6-dihydro-2-pyrone (5-acetoxyisogoniothalamin oxide) [123, 122] 
ConCluSIon
Literature actually reports chemical investigations of only forty species of Goniothalamus out of the 160 known species. There are no published data concerning either the toxicity of the whole remedies and the isolated compounds from new species of Goniothalamus. Despite the diversity of the genus and the numerous phytochemical constituents found, they have not been fully explored yet. Clinical investigation for new cytotoxic compounds is yet to be done. Further investigations on phytochemical discovery and subsequent screening are needed for opening new opportunities to develop pharmaceuticals based on Goniothalamus constituents.
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